98%
921
2 minutes
20
Background: Health care-based food assistance programs show promise but are underutilized. Strict eligibility requirements and program scheduling may dampen reach and outcomes.
Objective: To explore factors associated with uptake of a health center-based mobile produce market with no eligibility requirements and few barriers to entry.
Design: A cross-sectional analysis of medical record, sociodemographic, environmental, and market attendance data was used.
Participants/setting: The study sample consisted of 3071 adults (18+ years) who were patients of an urban health center in eastern Massachusetts and registered for the mobile market during the study period of August 2016 to February 2020.
Main Outcome Measures: The main outcome measure was monthly market attendance over the study period.
Statistical Analyses: T-tests and χ tests were used to compare market users and never-users. Multiple logistic regression was used to analyze variables associated with market attendance each month.
Results: In multiple variable analyses, Supplemental Nutrition Assistance Program enrollment was associated with slightly less frequent monthly market use (odds ratio [OR], 0.989; 95% CI, 0.984-0.994). Day-of, on-site market registration was associated with more frequent monthly use than self-registration on nonmarket days (OR, 1.08; 95% CI, 1.07-1.08). Having a psychiatric or substance use disorder diagnosis was associated with slightly less frequent market attendance (OR, 0.99; 95% CI, 0.98-0.99; and OR, 0.96; 95% CI, 0.95-0.97, respectively) compared with registrants without these diagnoses.
Conclusions: Individual, community-level, and organizational factors are associated with uptake of a free mobile produce market and should be considered when designing programs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jand.2024.04.008 | DOI Listing |
Neuropsychiatr Dis Treat
August 2025
Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, New York, USA.
Brexpiprazole is a second-generation antipsychotic with multiple indications, including the treatment of schizophrenia. As a partial dopamine agonist, brexpiprazole differs from most other antipsychotics, yet uncertainties about its full mechanism of action have led to some ambiguity among prescribers. To address this gap, an international panel of psychiatric experts was organized and convened with funding from Otsuka Pharmaceutical Europe Ltd and H.
View Article and Find Full Text PDFBMJ Open
September 2025
Salisbury NHS Foundation Trust, Salisbury, UK.
Introduction: Difficulty with walking can lead to reduced quality of life for people with Parkinson's disease (pwPD); improving walking is considered a treatment priority. Drug therapies can control PD symptoms; however, pwPD often still experience mobility problems.Functional electrical stimulation (FES) induces movement in weak muscles via external electrical stimulation.
View Article and Find Full Text PDFAlzheimers Dement
September 2025
Department of Clinical and Health Psychology, University of Florida, Gainesville, Florida, USA.
Introduction: Glial fibrillary acidic protein (GFAP) may contribute to Alzheimer's pathology at early disease stages. GFAP moderation of Alzheimer's disease (AD)-related neurodegeneration and cognition is unclear.
Methods: We examined plasma GFAP moderation of AD biomarkers (amyloid beta [Aβ]-positron emission tomography [PET][A]; plasma phosphorylated tau-181 [p-tau181][T]), neurodegeneration (plasma NfL[N]; structural magnetic resonance imaging [MRI][N]), and cognition (Cog; Cog) in two cohorts: University of California San Francisco (UCSF) (N = 212, 91.
Tob Induc Dis
August 2025
Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, United States.
Introduction: Some manufacturers of electronic nicotine delivery systems (ENDS) and liquids sell products with flavor names that use ambiguous terminology rather than explicitly characterize the product's flavor. These are often referred to as 'concept flavors'. This article presents a sample of ENDS concept flavor names to identify naming conventions the industry uses.
View Article and Find Full Text PDFGlob Reg Health Technol Assess
August 2025
VP Market Access & Healthcare Consulting Europe, Cencora, Munich - Germany.
The article explores the challenges and opportunities presented by the implementation of the EU Health Technology Assessment Regulation (EU HTAR). It highlights the varying degrees of readiness among Member States (MSs) and the perceived concerns regarding loss of sovereignty. The discussion emphasizes the importance of national preparedness, reducing bureaucratic inefficiencies, and fostering transparent communication among stakeholders.
View Article and Find Full Text PDF